General Biological Corporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares General Biological with three other
companies in this sector in TAIWAN :
sales of 305.69 million Taiwanese Dollars [US$10.45 million]
of which 100%
was Pharmaceutical Development),
Holy Stone Healthcare Co Ltd
(204.16 million Taiwanese Dollars [US$6.98 million]
Taiwan Advance Bio-Pharmaceutical Inc
(205.80 million Taiwanese Dollars [US$7.03 million]
General Biological reported sales of 239.65 million Taiwanese Dollars (US$8.19 million)
December of 2019.
decrease of 1.7%
versus 2018, when the company's sales were 243.81 million Taiwanese Dollars .